APA (7th ed.) Citation

DG, R., MG, S., & RF, B. (2016). First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 88(6), 899. https://doi.org/10.1002/ccd.26708

Chicago Style (17th ed.) Citation

DG, Rizik, Shah MG, and Burke RF. "First US Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold for the Treatment of Coronary Artery Disease." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 88, no. 6 (2016): 899. https://doi.org/10.1002/ccd.26708.

MLA (9th ed.) Citation

DG, Rizik, et al. "First US Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold for the Treatment of Coronary Artery Disease." Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, vol. 88, no. 6, 2016, p. 899, https://doi.org/10.1002/ccd.26708.